zolgensma® 2 × 10^13 vector genomes/ml infusion
alphamed drug store united states of america - 1 kit (5.5 ml or 8.3 ml single use vial x 2 to 14) - infusion - 2 × 10^13 vector genomes/ml - nervous system-modifying neuromuscular transmission
zolgensma suspension for injection
novartis europharm limited, ireland - onasemnogene abeparvovec - suspension for injection - 2000000000000 vg/ml,
solensia solution for injection for cats
zoetis australia pty ltd - frunevetmab - parenteral liquid/solution/suspension - frunevetmab active 7.0 mg - immunotherapy
zolgensma
novartis new zealand ltd - onasemnogene abeparvovec 20tvg/ml (tvg = tera vector genomes; equivalent to 2 x 10^13 vector genomes per ml); onasemnogene abeparvovec 20tvg/ml (tvg = tera vector genomes; equivalent to 2 x 10^13 vector genomes per ml) - solution for infusion - active: onasemnogene abeparvovec 20tvg/ml (tvg = tera vector genomes; equivalent to 2 x 10^13 vector genomes per ml) excipient: hydrochloric acid magnesium chloride poloxamer 188 sodium chloride trometamol water for injection active: onasemnogene abeparvovec 20tvg/ml (tvg = tera vector genomes; equivalent to 2 x 10^13 vector genomes per ml) excipient: hydrochloric acid magnesium chloride poloxamer 188 sodium chloride trometamol water for injection - zolgensma is an adeno-associated virus (aav) vector-based gene therapy indicated for the treatment of paediatric patients with spinal muscular atrophy (sma) with a bi allelic mutation in the survival motor neuron 1 (smn1) gene.
zolgensma
novartis new zealand ltd - onasemnogene abeparvovec 20tvg/ml (tvg = tera vector genomes; equivalent to 2 x 10^13 vector genomes per ml) - solution for infusion - active: onasemnogene abeparvovec 20tvg/ml (tvg = tera vector genomes; equivalent to 2 x 10^13 vector genomes per ml) excipient: hydrochloric acid magnesium chloride poloxamer 188 sodium chloride trometamol water for injection - zolgensma is an adeno-associated virus (aav) vector-based gene therapy indicated for the treatment of paediatric patients with spinal muscular atrophy (sma) with a bi allelic mutation in the survival motor neuron 1 (smn1) gene.
solensia solution
zoetis canada inc - frunevetmab - solution - 7mg - frunevetmab 7mg - cats
solensia 7 mg/ml solution for injection for cats
zoetis uk limited - frunevetmab - solution for injection - other analgesics and antipyretics - cats
dolgesia 325mg+37.5mg tablet, film coated
totalcare pharma inc - paracetamol , tramadol hydrochloride - tablet, film coated - 325mg+37.5mg
zolgensma®
1 kit (5.5 ml or 8.3 ml single use vial x 2 to 14) -
solensia 7 mg/ ml solution for injection (sc)
n/a; importer: zoetis philippines, inc.; distributor: zoetis philippines, inc. - frunevetmab (vet.) - solution for injection (sc) - 7 mg/ ml